⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 7, 2026

Neostig 0,5 mg Injektionslösung 0,5 mg (Injektionslösung)

📷 EU Safety Watch placeholder
Neostig 0,5 mg Injektionslösung 0,5 mg (Injektionslösung)
📷 EU Safety Watch placeholder
Parallel export ban in effect.
⚠️
Shortage ongoing
NEOSTIGMIN METILSULFAT is currently in short supply in AT.
📈 Timeline
118 days active so far
May 18, 2026 September 12, 2026

What is this? Neostig 0.5 mg is a medicine given by injection. It helps with muscle weakness.

What's happening? The medicine is not available right now. It will be back in stock soon.

Does this affect me? If you use this medicine, you may have trouble getting it now.

What should I do? Ask your pharmacist or doctor for advice before changing anything.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
NEOSTIGMIN METILSULFAT
Agency-published detail

🚫 Parallel export ban active · ATC: N07AA01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Wabosan Arzneimittelvertriebs GmbH, Anton-Anderer-Platz 6/1, 1210 Wien, Österreich · Affected packs: 10 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-04-07, resupply 2026-07-06]

First published
April 7, 2026
Last refreshed by us
2 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Neostig 0,5 mg Injektionslösung 0,5 mg (Injektionslösung). Parallel export ban in effect.
▸ When was this alert issued?
This alert was issued on April 7, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.